At vitamin D doses far higher than the human therapeutic range teratogenicity has been observed in animal studies. There is further no information of relevance to the safety assessment in addition to what is stated in other parts of the SPC.
Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.
By using this website, you consent to the use of cookies in accordance with the HPRA Cookie Policy. For more information on cookies, see our cookie policy.